Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 302 (5650): 1578-1581

Copyright © 2003 by the American Association for the Advancement of Science

Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease

Lejin Wang,1,2 Chun Fan,1,2 Sarah E. Topol,1 Eric J. Topol,1,3* Qing Wang1,2*

Abstract: The early genetic pathway(s) triggering the pathogenesis of coronary artery disease (CAD) and myocardial infarction (MI) remain largely unknown. Here, we describe an autosomal dominant form of CAD/MI (adCAD1) that is caused by the deletion of seven amino acids in transcription factor MEF2A. The deletion disrupts nuclear localization of MEF2A, reduces MEF2A-mediated transcription activation, and abolishes synergistic activation by MEF2A and by the transcription factor GATA-1 through a dominant-negative mechanism. The MEF2A protein demonstrates strong expression in the endothelium of coronary arteries. These results identify a pathogenic gene for a familial vascular disease with features of CAD and implicate the MEF2A signaling pathway in the pathogenesis of CAD/MI.

1 Center for Cardiovascular Genetics, Department of Cardiovascular Medicine, and Center for Molecular Genetics, Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation
2 Department of Molecular Medicine
3 Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195, USA.

* To whom correspondence should be addressed. E-mail: wangq2{at}ccf.org (Q.W.) and topole{at}ccf.org (E.J.T.)


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Reactivation of Fetal Splicing Programs in Diabetic Hearts Is Mediated by Protein Kinase C Signaling.
S. K. Verma, V. Deshmukh, P. Liu, C. A. Nutter, R. Espejo, M.-L. Hung, G.-S. Wang, G. W. Yeo, and M. N. Kuyumcu-Martinez (2013)
J. Biol. Chem. 288, 35372-35386
   Abstract »    Full Text »    PDF »
Genome-Wide Linkage Approach Yields Novel Early Onset Myocardial Infarction Locus in East Asians.
C. D. Anderson and J. Rosand (2013)
Circ Cardiovasc Genet 6, 531-532
   Full Text »    PDF »
Integrative genomics in cardiovascular medicine.
J. S. Ware, E. Petretto, and S. A. Cook (2013)
Cardiovasc Res 97, 623-630
   Abstract »    Full Text »    PDF »
Genetic Basis of Atherosclerosis: Insights From Mice and Humans.
I. M. Stylianou, R. C. Bauer, M. P. Reilly, and D. J. Rader (2012)
Circ. Res. 110, 337-355
   Abstract »    Full Text »    PDF »
Genetic determinants of coronary heart disease: new discoveries and insights from genome-wide association studies.
R. S. Patel and S. Ye (2011)
Heart 97, 1463-1473
   Abstract »    Full Text »    PDF »
Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian family.
G. Maiolino, S. Colonna, M. Zanchetta, L. Pedon, T. M. Seccia, M. Cesari, S. Vigili de Kreutzenberg, A. Avogaro, and G. P. Rossi (2011)
European Journal of Cardiovascular Prevention & Rehabilitation 18, 557-560
   Abstract »    Full Text »    PDF »
CAG Repeat Polymorphism of the MEF2A Gene is not Associated With the Risk of Coronary Artery Disease Among Taiwanese.
L.-A. Hsu, C.-J. Chang, M.-S. Teng, Semon Wu, C.-F. Hu, W.-Y. Chang, and Y.-L. Ko (2010)
Clinical and Applied Thrombosis/Hemostasis 16, 301-305
   Abstract »    PDF »
Regulatory polymorphism in transcription factor KLF5 at the MEF2 element alters the response to angiotensin II and is associated with human hypertension.
Y. Oishi, I. Manabe, Y. Imai, K. Hara, M. Horikoshi, K. Fujiu, T. Tanaka, T. Aizawa, T. Kadowaki, and R. Nagai (2010)
FASEB J 24, 1780-1788
   Abstract »    Full Text »    PDF »
Genetics of myocardial infarction: a progress report.
H. Schunkert, J. Erdmann, and N. J. Samani (2010)
Eur. Heart J. 31, 918-925
   Abstract »    Full Text »    PDF »
Novel Roles of GATA1 in Regulation of Angiogenic Factor AGGF1 and Endothelial Cell Function.
C. Fan, P. Ouyang, A. A. Timur, P. He, S.-A. You, Y. Hu, T. Ke, D. J. Driscoll, Q. Chen, and Q. K. Wang (2009)
J. Biol. Chem. 284, 23331-23343
   Abstract »    Full Text »    PDF »
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes.
A. Nebbioso, F. Manzo, M. Miceli, M. Conte, L. Manente, A. Baldi, A. De Luca, D. Rotili, S. Valente, A. Mai, et al. (2009)
EMBO Rep. 10, 776-782
   Abstract »    Full Text »    PDF »
Association and Functional Analyses of MEF2A as a Susceptibility Gene for Premature Myocardial Infarction and Coronary Artery Disease.
I. Guella, V. Rimoldi, R. Asselta, D. Ardissino, M. Francolini, N. Martinelli, D. Girelli, F. Peyvandi, M. Tubaro, P. A. Merlini, et al. (2009)
Circ Cardiovasc Genet 2, 165-172
   Abstract »    Full Text »    PDF »
Angiopoietin-1 Induces Kruppel-like Factor 2 Expression through a Phosphoinositide 3-Kinase/AKT-dependent Activation of Myocyte Enhancer Factor 2.
K. Sako, S. Fukuhara, T. Minami, T. Hamakubo, H. Song, T. Kodama, A. Fukamizu, J. S. Gutkind, G. Y. Koh, and N. Mochizuki (2009)
J. Biol. Chem. 284, 5592-5601
   Abstract »    Full Text »    PDF »
MEF2A Sequence Variants in Turkish Population.
S. Gulec, A. Ruchan Akar, and N. Akar (2008)
Clinical and Applied Thrombosis/Hemostasis 14, 465-467
   Abstract »    PDF »
Where Do We Go for Atherothrombotic Disease Genetics?.
S.-M. Brand-Herrmann (2008)
Stroke 39, 1070-1075
   Full Text »    PDF »
Identification of a New Co-factor, MOG1, Required for the Full Function of Cardiac Sodium Channel Nav1.5.
L. Wu, S. L. Yong, C. Fan, Y. Ni, S. Yoo, T. Zhang, X. Zhang, C. A. Obejero-Paz, H.-J. Rho, T. Ke, et al. (2008)
J. Biol. Chem. 283, 6968-6978
   Abstract »    Full Text »    PDF »
Lack of Association Between the MEF2A Gene and Myocardial Infarction.
W. Lieb, B. Mayer, I. R. Konig, I. Borwitzky, A. Gotz, S. Kain, C. Hengstenberg, P. Linsel-Nitschke, M. Fischer, A. Doring, et al. (2008)
Circulation 117, 185-191
   Abstract »    Full Text »    PDF »
USF1 Contributes to High Serum Lipid Levels in Dutch FCHL Families and U.S. Whites With Coronary Artery Disease.
J. C. Lee, D. Weissglas-Volkov, M. Kyttala, J. S. Sinsheimer, A. Jokiaho, T. W.A. de Bruin, A. J. Lusis, M.-L. Brennan, M. M.J. van Greevenbroek, C. J.H. van der Kallen, et al. (2007)
Arterioscler Thromb Vasc Biol 27, 2222-2227
   Abstract »    Full Text »    PDF »
Role of Kruppel-Like Transcription Factors in Endothelial Biology.
G. B. Atkins and M. K. Jain (2007)
Circ. Res. 100, 1686-1695
   Abstract »    Full Text »    PDF »
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group.
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al. (2007)
Circulation 115, 2878-2901
   Abstract »    Full Text »    PDF »
Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility.
Y.-X. Wang, L.-X. Qian, D. Liu, L.-L. Yao, Q. Jiang, Z. Yu, Y.-H. Gui, T. P. Zhong, and H.-Y. Song (2007)
Cardiovasc Res 74, 290-303
   Abstract »    Full Text »    PDF »
Immunomodulation Strategies for Preventing Vascular Disease of the Brain and Heart: Workshop Summary.
J. Hallenbeck, G. del Zoppo, T. Jacobs, A. Hakim, S. Goldman, U. Utz, A. Hasan, and for the Immunomodulation Workshop Participants (2006)
Stroke 37, 3035-3042
   Abstract »    Full Text »    PDF »
Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses.
D. Keen-Kim, C. A. Mathews, V. I. Reus, T. L. Lowe, L. D. Herrera, C. L. Budman, V. Gross-Tsur, A. E. Pulver, R. D. Bruun, G. Erenberg, et al. (2006)
Hum. Mol. Genet. 15, 3324-3328
   Abstract »    Full Text »    PDF »
Genetic susceptibility to myocardial infarction and coronary artery disease.
E. J. Topol, J. Smith, E. F. Plow, and Q. K. Wang (2006)
Hum. Mol. Genet. 15, R117-R123
   Abstract »    Full Text »    PDF »
Identification of a CRYAB Mutation Associated with Autosomal Dominant Posterior Polar Cataract in a Chinese Family..
M. Liu, T. Ke, Z. Wang, Q. Yang, W. Chang, F. Jiang, Z. Tang, H. Li, X. Ren, X. Wang, et al. (2006)
Invest. Ophthalmol. Vis. Sci. 47, 3461-3466
   Abstract »    Full Text »    PDF »
The genetics of heart attack..
E. J Topol (2006)
Heart 92, 855-861
   Full Text »    PDF »
Mapping a new genetic locus for X linked retinitis pigmentosa to Xq28..
A Melamud, G-Q Shen, D Chung, Q Xi, E Simpson, L Li, N S Peachey, H Zegarra, S A Hagstrom, Q K Wang, et al. (2006)
J. Med. Genet. 43, e27
   Abstract »    Full Text »    PDF »
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations.
R. S. Vasan (2006)
Circulation 113, 2335-2362
   Full Text »    PDF »
Cardiovascular Genomics.
M. S. Sabatine, J. G. Seidman, and C. E. Seidman (2006)
Circulation 113, e450-e455
   Full Text »    PDF »
Myospryn Is a Direct Transcriptional Target for MEF2A That Encodes a Striated Muscle, {alpha}-Actinin-interacting, Costamere-localized Protein.
J. T. Durham, O. M. Brand, M. Arnold, J. G. Reynolds, L. Muthukumar, H. Weiler, J. A. Richardson, and F. J. Naya (2006)
J. Biol. Chem. 281, 6841-6849
   Abstract »    Full Text »    PDF »
Common Genetic Vulnerability to Depressive Symptoms and Coronary Artery Disease: A Review and Development of Candidate Genes Related to Inflammation and Serotonin.
J. M. McCaffery, N. Frasure-Smith, M.-P. Dube, P. Theroux, G. A. Rouleau, Q. Duan, and F. Lesperance (2006)
Psychosom Med 68, 187-200
   Abstract »    Full Text »    PDF »
Control of MEF2 Transcriptional Activity by Coordinated Phosphorylation and Sumoylation.
S. Gregoire, A. M. Tremblay, L. Xiao, Q. Yang, K. Ma, J. Nie, Z. Mao, Z. Wu, V. Giguere, and X.-J. Yang (2006)
J. Biol. Chem. 281, 4423-4433
   Abstract »    Full Text »    PDF »
The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction.
P Gonzalez, M Garcia-Castro, J R Reguero, A Batalla, A G Ordonez, R L Palop, I Lozano, M Montes, V Alvarez, and E Coto (2006)
J. Med. Genet. 43, 167-169
   Abstract »    Full Text »    PDF »
Molecular evidence for arterial repair in atherosclerosis.
R. Karra, S. Vemullapalli, C. Dong, E. E. Herderick, X. Song, K. Slosek, J. R. Nevins, M. West, P. J. Goldschmidt-Clermont, and D. Seo (2005)
PNAS 102, 16789-16794
   Abstract »    Full Text »    PDF »
Transcriptional Regulation of Tissue-Specific Genes by the ERK5 Mitogen-Activated Protein Kinase.
S. J. Sohn, D. Li, L. K. Lee, and A. Winoto (2005)
Mol. Cell. Biol. 25, 8553-8566
   Abstract »    Full Text »    PDF »
MEF2-dependent Recruitment of the HAND1 Transcription Factor Results in Synergistic Activation of Target Promoters.
S. Morin, G. Pozzulo, L. Robitaille, J. Cross, and M. Nemer (2005)
J. Biol. Chem. 280, 32272-32278
   Abstract »    Full Text »    PDF »
Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells.
S. Sen-Banerjee, S. Mir, Z. Lin, A. Hamik, G. B. Atkins, H. Das, P. Banerjee, A. Kumar, and M. K. Jain (2005)
Circulation 112, 720-726
   Abstract »    Full Text »    PDF »
Complex Trait Locus Linkage Mapping in Atherosclerosis: Time to Take a Step Back Before Moving Forward?.
R. L. Pollex and R. A. Hegele (2005)
Arterioscler Thromb Vasc Biol 25, 1541-1544
   Full Text »    PDF »
Recent Advances in Cardiac Development With Therapeutic Implications for Adult Cardiovascular Disease.
J. A. Epstein and M. S. Parmacek (2005)
Circulation 112, 592-597
   Full Text »    PDF »
Tumor Necrosis Factor Alpha-Mediated Reduction of KLF2 Is Due to Inhibition of MEF2 by NF-{kappa}B and Histone Deacetylases.
A. Kumar, Z. Lin, S. SenBanerjee, and M. K. Jain (2005)
Mol. Cell. Biol. 25, 5893-5903
   Abstract »    Full Text »    PDF »
Heritability and a Genome-Wide Linkage Scan for Arterial Stiffness, Wave Reflection, and Mean Arterial Pressure: The Framingham Heart Study.
G. F. Mitchell, A. L. DeStefano, M. G. Larson, E. J. Benjamin, M.-H. Chen, R. S. Vasan, J. A. Vita, and D. Levy (2005)
Circulation 112, 194-199
   Abstract »    Full Text »    PDF »
Myocyte Enhancer Factor 2 Acetylation by p300 Enhances Its DNA Binding Activity, Transcriptional Activity, and Myogenic Differentiation.
K. Ma, J. K. L. Chan, G. Zhu, and Z. Wu (2005)
Mol. Cell. Biol. 25, 3575-3582
   Abstract »    Full Text »    PDF »
Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication.
X.-J. Yang and S. Gregoire (2005)
Mol. Cell. Biol. 25, 2873-2884
   Full Text »    PDF »
Association with Class IIa Histone Deacetylases Upregulates the Sumoylation of MEF2 Transcription Factors.
S. Gregoire and X.-J. Yang (2005)
Mol. Cell. Biol. 25, 2273-2287
   Abstract »    Full Text »    PDF »
Hairy-related Transcription Factors Inhibit GATA-dependent Cardiac Gene Expression through a Signal-responsive Mechanism.
I. S. Kathiriya, I. N. King, M. Murakami, M. Nakagawa, J. M. Astle, K. A. Gardner, R. D. Gerard, E. N. Olson, D. Srivastava, and O. Nakagawa (2004)
J. Biol. Chem. 279, 54937-54943
   Abstract »    Full Text »    PDF »
Genome-Wide Linkage Scan Identifies a Novel Genetic Locus on Chromosome 5p13 for Neonatal Atrial Fibrillation Associated With Sudden Death and Variable Cardiomyopathy.
C. Oberti, L. Wang, L. Li, J. Dong, S. Rao, W. Du, and Q. Wang (2004)
Circulation 110, 3753-3759
   Abstract »    Full Text »    PDF »
Transcription factor MEF2A mutations in patients with coronary artery disease.
M.R. K. Bhagavatula, C. Fan, G.-Q. Shen, J. Cassano, E. F. Plow, E. J. Topol, and Q. Wang (2004)
Hum. Mol. Genet. 13, 3181-3188
   Abstract »    Full Text »    PDF »
Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways.
A. J. Lusis, A. M. Fogelman, and G. C. Fonarow (2004)
Circulation 110, 1868-1873
   Full Text »    PDF »
Cardiovascular genetics: are we there yet?.
A C Sturm (2004)
J. Med. Genet. 41, 321-323
   Full Text »    PDF »
Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes.
J J McCarthy, A Parker, R Salem, D J Moliterno, Q Wang, E F Plow, S Rao, G Shen, W J Rogers, L K Newby, et al. (2004)
J. Med. Genet. 41, 334-341
   Abstract »    Full Text »    PDF »
Genomics in Sudden Cardiac Death.
D. E. Arking, S. S. Chugh, A. Chakravarti, and P. M. Spooner (2004)
Circ. Res. 94, 712-723
   Abstract »    Full Text »    PDF »
Cardiovascular News.
R. SoRelle (2003)
Circulation 108, e9077-e9078
   Full Text »
Coronary Artery Disease and the MEF2A Transcription Factor.
E. N. Olson (2003)
Sci. Aging Knowl. Environ. 2003, pe33-33
   Abstract »    Full Text »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882